Clinical Trial Update: Combination Iron Chelation Therapy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a combination iron chelation therapy for iron overload and thalassemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Thalassemia

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Iron Overload, Thalassemia | Phase 1 | Status: COMPLETED